133
Views
1
CrossRef citations to date
0
Altmetric
Research Articles

Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

, , , , , , , , & show all
Pages 441-450 | Received 26 Oct 2023, Accepted 13 Feb 2024, Published online: 26 Feb 2024

References

  • Goto M, Al-Hasan MN. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe. Clin Microbiol Infect. 2013;19(6):501–509. doi: 10.1111/1469-0691.12195.
  • Schechner V, Wulffhart L, Temkin E, et al. One-year mortality and years of potential life lost following bloodstream infection among adults: a nation-wide population based study. Lancet Reg Health Eur. 2022;23:100511. doi: 10.1016/j.lanepe.2022.100511.
  • Hindy JR, Quintero-Martinez JA, Lee AT, et al. Incidence trends and epidemiology of Staphylococcus aureus bacteremia: a systematic review of population-based studies. Cureus. 2022;14(5):e25460. doi: 10.7759/cureus.25460.
  • Suzuki M, Satoh N, Nakamura M, et al. Bacteremia in hemodialysis patients. World J Nephrol. 2016;5(6):489–496. doi: 10.5527/wjn.v5.i6.489.
  • Taramasso L, Tatarelli P, Di Biagio A. Bloodstream infections in HIV-infected patients. Virulence. 2016;7(3):320–328. doi: 10.1080/21505594.2016.1158359.
  • Pérez-Crespo PMM, Lanz-García JF, Bravo-Ferrer J, et al. Revisiting the epidemiology of bloodstream infections and healthcare-associated episodes: results from a multicentre prospective cohort in Spain (PRO-BAC study). Int J Antimicrob Agents. 2021;58(1):106352. doi: 10.1016/j.ijantimicag.2021.106352.
  • Skogberg K, Lyytikäinen O, Ollgren J, et al. Population-based burden of bloodstream infections in Finland. Clin Microbiol Infect. 2012;18(6):E170–E176. doi: 10.1111/j.1469-0691.2012.03845.x.
  • Laupland KB, Kibsey PC, Gregson DB, et al. Population-based laboratory assessment of the burden of community-onset bloodstream infection in Victoria, Canada. Epidemiol Infect. 2013;141(1):174–180. doi: 10.1017/S0950268812000428.
  • Nielsen SL, Pedersen C, Jensen TG, et al. Decreasing incidence rates of bacteremia: a 9-year population-based study. J Infect. 2014;69(1):51–59. doi: 10.1016/j.jinf.2014.01.014.
  • Holmbom M, Giske CG, Fredrikson M, et al. 14-Year survey in a Swedish county reveals a pronounced increase in bloodstream infections (BSI). Comorbidity – an independent risk factor for both BSI and mortality. PLOS One. 2016;11(11):e0166527. doi: 10.1371/journal.pone.0166527.
  • Laupland KB, Pasquill K, Parfitt EC, et al. Burden of community-onset bloodstream infections, Western interior, British Columbia, Canada. Epidemiol Infect. 2016;144(11):2440–2446. doi: 10.1017/S0950268816000613.
  • Mehl A, Åsvold BO, Lydersen S, et al. Burden of bloodstream infection in an area of Mid-Norway 2002–2013: a prospective population-based observational study. BMC Infect Dis. 2017;17(1):205. doi: 10.1186/s12879-017-2291-2.
  • Buetti N, Atkinson A, Marschall J, et al. Incidence of bloodstream infections: a nationwide surveillance of acute care hospitals in Switzerland 2008–2014. BMJ Open. 2017;7(3):e013665. doi: 10.1136/bmjopen-2016-013665.
  • Rhodes J, Jorakate P, Makprasert S, et al. Population-based bloodstream infection surveillance in rural Thailand, 2007–2014. BMC Public Health. 2019;19(Suppl. 3):521. doi: 10.1186/s12889-019-6775-4.
  • Kontula KSK, Skogberg K, Ollgren J, et al. Population-based study of bloodstream infection incidence and mortality rates, Finland, 2004–2018. Emerg Infect Dis. 2021;27(10):2560–2569. doi: 10.3201/eid2710.204826.
  • Verway M, Brown KA, Marchand-Austin A, et al. Prevalence and mortality associated with bloodstream organisms: a population-wide retrospective cohort study. J Clin Microbiol. 2022;60(4):e0242921. doi: 10.1128/jcm.02429-21.
  • Weinstein MP, Towns ML, Quartey SM, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24(4):584–602. doi: 10.1093/clinids/24.4.584.
  • Rodríguez-Créixems M, Alcalá L, Muñoz P, et al. Bloodstream infections: evolution and trends in the microbiology workload, incidence, and etiology, 1985–2006. Medicine. 2008;87(4):234–249. doi: 10.1097/MD.0b013e318182119b.
  • World Health Organization. Global antimicrobial resistance and use surveillance system (GLASS) report; 2021 [cite 2023 Nov]. Available from: https://www.who.int/publications/i/item/9789240027336
  • Alonso-Menchén D, Muñoz P, Sánchez-Carrillo C, et al. Unresolved issues in the epidemiology and diagnosis of bacteremia: an opinion paper. Rev Esp Quimioter. 2022;35(6):519–537.
  • Rodríguez Díaz JC, Guna Serrano M, Larrosa Escartín N, et al. Diagnóstico microbiológico de la bacteriemia y la fungemia: hemocultivos y métodos moleculares. 2017. Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC); 2017.
  • Clinical and Laboratory Standards Institute (CLSI). Principles and procedures for blood cultures. 2nd ed. CLSI Guideline M47; 2022.
  • Instituto de Estadística. Comunidad de Madrid. Padrón anual. Resultados detallados. Series anuales; 2023 [cited 2023 Nov]. Available from: https://www.madrid.org/iestadis/fijas/estructu/demograficas/padron/estructupcrd.htm
  • Baron EJ, Weinstein MP, Dunne MW, et al. Cumitech 1C, blood cultures IV. Washington (DC): ASM Press; 2005.
  • Diekema DJ, Hsueh PR, Mendes RE, et al. The microbiology of bloodstream infection: 20-year trends from the SENTRY Antimicrobial Surveillance Program. Antimicrob Agents Chemother. 2019;63(7):e00355-19. doi: 10.1128/AAC.00355-19.
  • Monticelli J, Di Bella S, Giacobbe DR, et al. Trends in the incidence and antibiotic resistance of enterococcal bloodstream isolates: a 7-year retrospective multicenter epidemiological study in Italy. Microb Drug Resist. 2021;27(4):529–535. doi: 10.1089/mdr.2020.0147.
  • Moberley S, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013;2013(1):CD000422. doi: 10.1002/14651858.CD000422.pub3.
  • Dirección General de Salud Pública. Consejería de Sanidad. Comunidad de Madrid. Vacunación frente a neumococo en el adulto. Información para profesionales sanitarios; 2022 [cited 2024 Jan]. Available from: https://www.comunidad.madrid/servicios/salud/vacunas-informacion-profesionales
  • Martínez Pérez-Crespo PM, López-Cortés LE, Retamar-Gentil P, et al. Epidemiologic changes in bloodstream infections in Andalucía (Spain) during the last decade. Clin Microbiol Infect. 2021;27(2):283.e9–283.e16. doi: 10.1016/j.cmi.2020.05.015.
  • Hindy JR, Quintero-Martinez JA, Lahr BD, et al. Incidence of monomicrobial Staphylococcus aureus bacteremia: a population-based study in Olmsted county, Minnesota-2006 to 2020. Open Forum Infect Dis. 2022;9(7):ofac190. doi: 10.1093/ofid/ofac190.
  • Gagliotti C, Högberg LD, Billström H, et al. Staphylococcus aureus bloodstream infections: diverging trends of methicillin-resistant and methicillin-susceptible isolates, EU/EEA, 2005 to 2018. Euro Surveill. 2021;26(46): 2002094. doi: 10.2807/1560-7917.ES.2021.26.46.2002094.
  • Ryan L, O'Mahony E, Wrenn C, et al. Epidemiology and molecular typing of VRE bloodstream isolates in an Irish Tertiary Care Hospital. J Antimicrob Chemother. 2015;70(10):2718–2724. doi: 10.1093/jac/dkv185.
  • Iacchini S, Sabbatucci M, Gagliotti C, et al. Bloodstream infections due to carbapenemase-producing Enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017. Euro Surveill. 2019;24(5):1800159.
  • Bouza E, Sousa D, Rodríguez-Créixems M, et al. Is the volume of blood cultured still a significant factor in the diagnosis of bloodstream infections? J Clin Microbiol. 2007;45(9):2765–2769. doi: 10.1128/JCM.00140-07.
  • Grupo de trabajo EPINE. Encuesta de Prevalencia de infecciones relacionadas con la asistencia sanitaria y uso de antimicrobianos en hospitales de agudos en España 2012–2021. Madrid: Grupo de trabajo EPINE; 2022.
  • Bonazzetti C, Morena V, Giacomelli A, et al. Unexpectedly high frequency of enterococcal bloodstream infections in coronavirus disease 2019 patients admitted to an Italian ICU: an observational study. Crit Care Med. 2021;49(1):e31–e40. doi: 10.1097/CCM.0000000000004748.
  • Sepulveda J, Westblade LF, Whittier S, et al. Bacteremia and blood culture utilization during COVID-19 surge in New York City. J Clin Microbiol. 2020;58(8): e00875-20. doi: 10.1128/JCM.00875-20.
  • Centers for Disease Control and Prevention. 2020 National and State Healthcare-Associated Infections Progress Report; 2020 [cited 2023 Mar]. Available from: https://www.cdc.gov/hai/data/archive/archive.html
  • ENVIN COVID. Estudio nacional de vigilancia de infección nosocomial en servicios de medicina intensiva. Oleada 2. Informe; 2020 [cited 2023 Mar]. Available from: https://semicyuc.org/envin
  • Pérez-Granda MJ, Carrillo CS, Rabadán PM, et al. Increase in the frequency of catheter-related bloodstream infections during the COVID-19 pandemic: a plea for control. J Hosp Infect. 2022;119:149–154. doi: 10.1016/j.jhin.2021.09.020.
  • Dantes RB, Abbo LM, Anderson D, et al. Hospital epidemiologists’ and infection preventionists’ opinions regarding hospital-onset bacteremia and fungemia as a potential healthcare-associated infection metric. Infect Control Hosp Epidemiol. 2019;40(5):536–540. doi: 10.1017/ice.2019.40.
  • Zhu N, Rawson TM, Mookerjee S, et al. Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: a retrospective analysis using data linkage. Clin Infect Dis. 2021;75(1):e1082–e1091. doi: 10.1093/cid/ciab869.
  • DeVoe C, Segal MR, Wang L, et al. Increased rates of secondary bacterial infections, including enterococcus bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19). Infect Control Hosp Epidemiol. 2022;43(10):1416–1423. doi: 10.1017/ice.2021.391.
  • Giacobbe DR, Labate L, Tutino S, et al. Enterococcal bloodstream infections in critically ill patients with COVID-19: a case series. Ann Med. 2021;53(1):1779–1786. doi: 10.1080/07853890.2021.1988695.
  • Lamers MM, Beumer J, van der Vaart J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50–54. doi: 10.1126/science.abc1669.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.